Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Poland Principal Investigator

Femme et Homme Max 99 ans
Poland Principal Investigator MAJ Il y a 4 ans

A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer The purpose of this study is to evaluate survival, response rate, safety and tolerability of YM155 given in combination with docetaxel as first-line treatment in subjects with human epider...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations